Market Place
Sourcing Support
TELA Bio Announces Q2 2025 Financial Results
11 Aug 2025 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)
08 Aug 2025 //
GLOBENEWSWIRE
TELA Bio Joins Canaccord Genuity 45th Annual Growth Conference
23 Jul 2025 //
GLOBENEWSWIRE
TELA Bio Announces Q2 2025 Financial Results
21 Jul 2025 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
06 Jun 2025 //
GLOBENEWSWIRE
Tela Bio Launches OviTex Inguinal for Hernia Repair in Europe
03 Jun 2025 //
GLOBENEWSWIRE
TELA Bio Appoints Jeffrey Blizard as President
02 Jun 2025 //
GLOBENEWSWIRE
Tela Bio at 2025 Jefferies Global Healthcare Conference
22 May 2025 //
GLOBENEWSWIRE
Tela Bio Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)
09 May 2025 //
GLOBENEWSWIRE
TELA Bio Reports First Quarter 2025 Financial Results
08 May 2025 //
GLOBENEWSWIRE
TELA Bio to Announce First Quarter 2025 Financial Results
17 Apr 2025 //
GLOBENEWSWIRE
TELA Bio Launches Larger OviTex PRS for Plastic Surgery in U.S.
31 Mar 2025 //
GLOBENEWSWIRE
TELA Bio Reports Q4 & 2024 Financial Results
20 Mar 2025 //
GLOBENEWSWIRE
TELA Bio to Announce Q4 and Full Year 2024 Financial Results
27 Feb 2025 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
21 Feb 2025 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
24 Jan 2025 //
GLOBENEWSWIRE
TELA Bio Grants Inducements Under Nasdaq LR 5635(c)(4)
13 Dec 2024 //
GLOBENEWSWIRE
Tela Bio To Present At Piper Sandler’s 36th Annual Conference
19 Nov 2024 //
GLOBENEWSWIRE
TELA Bio Reports Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
01 Nov 2024 //
GLOBENEWSWIRE
TELA Bio Closes Public Offering And Underwriters’ Option
24 Oct 2024 //
GLOBENEWSWIRE
TELA Bio Prices Public Offering of Stock and Warrants
23 Oct 2024 //
GLOBENEWSWIRE
TELA Bio Proposes Public Offering Of Common Stock And Warrants
22 Oct 2024 //
GLOBENEWSWIRE
TELA Bio to Announce Third Quarter 2024 Financial Results
17 Oct 2024 //
GLOBENEWSWIRE
TELA Bio Reports Q2 2024 Results, Reiterates 2024 Revenue Guidance
12 Aug 2024 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 Aug 2024 //
GLOBENEWSWIRE
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
25 Jul 2024 //
GLOBENEWSWIRE
TELA Bio to Announce Second Quarter 2024 Financial Results
22 Jul 2024 //
GLOBENEWSWIRE
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
04 Jun 2024 //
GLOBENEWSWIRE
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
20 May 2024 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 May 2024 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule
10 May 2024 //
PRESS RELEASE
TELA Bio Reports First Quarter 2024 Financial Results
09 May 2024 //
GLOBENEWSWIRE
TELA Bio to Announce First Quarter 2024 Financial Results
25 Apr 2024 //
GLOBENEWSWIRE
TELA Bio US Launches Robotic OviTex® IHR For Hernias
15 Apr 2024 //
GLOBENEWSWIRE
TELA Welcomes Acclaimed Surgeon as VP of Medical Affairs and Surgeon Strategy
08 Apr 2024 //
GLOBENEWSWIRE
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX for Hernia Surgery
21 Mar 2024 //
GLOBENEWSWIRE
TELA Bio Achieves Record Fourth Quarter and FY23 Revenues and Reports
21 Mar 2024 //
GLOBENEWSWIRE
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
20 Mar 2024 //
GLOBENEWSWIRE
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23 Feb 2024 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 Jan 2024 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Dec 2023 //
GLOBENEWSWIRE
TELA Bio to Take Part in Connecting the Dots
05 Dec 2023 //
GLOBENEWSWIRE
TELA Bio to Participate in Piper Sandler™s 35th Annual Healthcare Conference
16 Nov 2023 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Nov 2023 //
GLOBENEWSWIRE
TELA Bio Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
TELA Bio to Announce Third Quarter 2023 Financial Results
26 Oct 2023 //
GLOBENEWSWIRE
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
18 Sep 2023 //
GLOBENEWSWIRE
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable
16 Aug 2023 //
GLOBENEWSWIRE
TELA Bio Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 //
GLOBENEWSWIRE
TELA Bio to Announce Second Quarter 2023 Financial Results
26 Jul 2023 //
GLOBENEWSWIRE
New Survey Finds Strong Consumer Preference for More Natural Hernia Repair
15 Jun 2023 //
GLOBENEWSWIRE
TELA Bio to Participate in the Jefferies Global Healthcare Conference
25 May 2023 //
GLOBENEWSWIRE
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
19 May 2023 //
GLOBENEWSWIRE
TELA Bio Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration
09 May 2023 //
GLOBENEWSWIRE
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 May 2023 //
GLOBENEWSWIRE
TELA Bio to Participate in the JMP Securities Life Sciences Conference
02 May 2023 //
GLOBENEWSWIRE
